SANTA MONICA, Calif.–(BUSINESS WIRE)–Feb. 10, 2020– Kite, a Gilead Company (Nasdaq: GILD),
Read moreU.S. FDA Grants Priority Review for Kite’s KTE-X19 Biologics License Application (BLA) in Relapsed or Refractory Mantle Cell Lymphoma
New drug that could aid MS diagnoses approved for human trials by FDA
A new drug that could make it easier for doctors
Read moreWhy your generic drugs may not be safe and the FDA may be too lax
Generic prescription drugs have saved the U.S. about US$1.7 trillion
Read moreThe first drug in Hong Kong to be granted orphan drug designation by the US FDA
A research team from the School of Chinese Medicine at
Read moreAlbireo Announces FDA Clearance of IND to Commence Phase 2 Trial of Elobixibat for the Treatment of NAFLD/NASH
BOSTON, April 11, 2019 (GLOBE NEWSWIRE) — Albireo Pharma, Inc.
Read moreNovo Nordisk Files for US FDA Approval of Oral Semaglutide for Blood Sugar Control and Cardiovascular Risk Reduction in Adults with Type 2 Diabetes
PLAINSBORO, N.J., March 20, 2019 /PRNewswire/ — Novo Nordisk today
Read moreFDA Approves First Immunotherapy Drug for Breast Cancer
MONDAY, March 11, 2019 — The U.S. Food and Drug
Read moreFDA Expands Indication for Soliqua 100/33 (insulin glargine and lixisenatide injection) to Include Type 2 Diabetes Patients Uncontrolled on Oral Antidiabetic Medicines
BRIDGEWATER, N.J., Feb. 27, 2019 /PRNewswire/ — The U.S. Food
Read moreDon’t Be Fooled: Thermography No Substitute for Mammograms, FDA Says
MONDAY, Feb. 25, 2019 — Women should not be misled
Read moreFDA Panel Backs Ketamine-Like Drug for Depression
WEDNESDAY, Feb. 13, 2019 — An expert panel for the
Read more